Related Experiment Videos
Lysosomal disorders
1Willink Biochemical Genetics Unit, Royal Manchester Children's Hospital, Manchester, UK. ed@willink.demon.co.uk
Insights
Lysosomal storage disorders (LSDs) often present in infancy but can manifest dramatically in newborns. Accurate diagnosis is crucial for potential future prenatal testing, as curative treatments remain limited.
Area of Science:
- Biochemistry
- Genetics
- Pediatrics
Background:
- Lysosomal storage disorders (LSDs) are a group of genetic conditions.
- While typically presenting in infancy or early childhood, some LSDs exhibit a neonatal phenotype.
- Genetic heterogeneity contributes to the diverse clinical spectrum of LSDs.
Purpose of the Study:
- To review the presentation and diagnosis of lysosomal storage disorders, particularly in the neonatal period.
- To highlight the challenges in diagnosing and treating these rare genetic conditions.
- To emphasize the importance of accurate diagnosis for genetic counseling and future reproductive options.
Main Methods:
- Review of clinical presentations and diagnostic approaches for lysosomal storage disorders.
- Discussion of radiological studies and peripheral blood/bone marrow smear findings.
- Exploration of current and emerging therapeutic strategies.
Main Results:
- Lysosomal storage disorders display significant genetic heterogeneity, leading to varied clinical presentations.
- Neonatal presentation can be dramatic, sometimes associated with non-immune hydrops fetalis.
- Diagnostic tools include imaging and examination of blood or bone marrow samples.
Conclusions:
- Accurate diagnosis of lysosomal storage disorders is essential, despite limited curative treatments.
- Emerging therapies like enzyme replacement and substrate deprivation offer potential prognostic improvements.
- Establishing a diagnosis enables prenatal testing for future pregnancies, aiding family planning.
Abstract:
Although most lysosomal storage disorders present in infancy or early childhood with a progressive condition often associated with dysmorphism, considerable genetic heterogeneity exists resulting in a range of illnesses that can include a dramatic neonatal presentation. Whilst some conditions present with a characteristic neonatal phenotype (e.g. Niemann-Pick disease type C), the remainder present in a nonspecific way often with non-immune hydrops fetalis. Diagnosis can be helped by appropriate radiological studies and, in some patients, evidence of the storage phenomena can be seen in peripheral blood smears or bone marrow aspirates. Unfortunately, for the majority of affected patients no effective, curative, treatment is possible. New developments in therapy including enzyme replacement therapy and substrate deprivation may improve prognosis in some disorders. It is important to establish an accurate diagnosis, as prenatal testing can then be offered in future pregnancies.